Correlation Between Enzolytics and Therasense

Can any of the company-specific risk be diversified away by investing in both Enzolytics and Therasense at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzolytics and Therasense into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enzolytics and Therasense, you can compare the effects of market volatilities on Enzolytics and Therasense and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzolytics with a short position of Therasense. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzolytics and Therasense.

Diversification Opportunities for Enzolytics and Therasense

0.0

Correlation Coefficient

Enzolytics  Therasense

Pay attention - limited upside

The 3 months correlation between Enzolytics and Therasense is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Enzolytics and Therasense in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Therasense and Enzolytics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzolytics are associated (or correlated) with Therasense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Therasense has no effect on the direction of Enzolytics i.e., Enzolytics and Therasense go up and down completely randomly.

Pair Corralation between Enzolytics and Therasense

If you would invest  0.01  in Therasense on December 24, 2024 and sell it today you would earn a total of  0.00  from holding Therasense or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.36%
Values	Daily Returns

Enzolytics  vs.  Therasense

Enzolytics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Enzolytics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Therasense

Risk-Adjusted Performance

Very Weak

Over the last 90 days Therasense has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Therasense is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Enzolytics and Therasense

The main advantage of trading using opposite Enzolytics and Therasense positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzolytics position performs unexpectedly, Therasense can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Therasense will offset losses from the drop in Therasense's long position.

The idea behind Enzolytics and Therasense pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.